{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:01:40Z","timestamp":1791144100520,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Retrovirology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1742-4690-11-8","type":"journal-article","created":{"date-parts":[[2014,1,20]],"date-time":"2014-01-20T18:01:25Z","timestamp":1390240885000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Passive immunization of macaques with polyclonal anti-SHIV IgG against a heterologous tier 2 SHIV: outcome depends on IgG dose"],"prefix":"10.1186","volume":"11","author":[{"given":"Anton M","family":"Sholukh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddappa N","family":"Byrareddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivekanandan","family":"Shanmuganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish","family":"Hemashettar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir K","family":"Lakhashe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer D","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemant K","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Thorat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Brandstoetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad M","family":"Mukhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John K","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis J","family":"Novembre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Villinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Landucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald N","family":"Forthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Ratcliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iskra","family":"Tuero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjorie","family":"Robert-Guroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria R","family":"Polonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslawa","family":"Bilska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C","family":"Montefiori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Welkin E","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hildegund C","family":"Ertl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth M","family":"Ruprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,20]]},"reference":[{"key":"3871_CR1","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","volume":"366","author":"BF Haynes","year":"2012","unstructured":"Haynes BF, Gilbert PB, McElrath MJ, Zolla-Pazner S, Tomaras GD, Alam SM, Evans DT, Montefiori DC, Karnasuta C, Sutthent R, et al: Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N Engl J Med. 2012, 366: 1275-1286.","journal-title":"N Engl J Med"},{"key":"3871_CR2","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.coviro.2011.07.005","volume":"1","author":"SK Lakhashe","year":"2011","unstructured":"Lakhashe SK, Silvestri G, Ruprecht RM: No acquisition: a new ambition for HIV vaccine development?. Curr Opin Virol. 2011, 1: 246-253.","journal-title":"Curr Opin Virol"},{"key":"3871_CR3","doi-asserted-by":"publisher","first-page":"6944","DOI":"10.1073\/pnas.85.18.6944","volume":"85","author":"AM Prince","year":"1988","unstructured":"Prince AM, Horowitz B, Baker L, Shulman RW, Ralph H, Valinsky J, Cundell A, Brotman B, Boehle W, Rey F, et al: Failure of a human immunodeficiency virus (HIV) immune globulin to protect chimpanzees against experimental challenge with HIV. Proc Natl Acad Sci USA. 1988, 85: 6944-6948.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3871_CR4","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1089\/aid.1991.7.971","volume":"7","author":"AM Prince","year":"1991","unstructured":"Prince AM, Reesink H, Pascual D, Horowitz B, Hewlett I, Murthy KK, Cobb KE, Eichberg JW: Prevention of HIV infection by passive immunization with HIV immunoglobulin. AIDS Res Hum Retroviruses. 1991, 7: 971-973.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"3871_CR5","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1089\/aid.1992.8.1515","volume":"8","author":"JW Eichberg","year":"1992","unstructured":"Eichberg JW, Murthy KK, Ward RH, Prince AM: Prevention of HIV infection by passive immunization with HIVIG or CD4-IgG. AIDS Res Hum Retroviruses. 1992, 8: 1515-","journal-title":"AIDS Res Hum Retroviruses"},{"key":"3871_CR6","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1073\/pnas.98.2.658","volume":"98","author":"T Igarashi","year":"2001","unstructured":"Igarashi T, Brown CR, Endo Y, Buckler-White A, Plishka R, Bischofberger N, Hirsch V, Martin MA: Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus\/HIV type 1 chimera (SHIV): implications for HIV-1 infections of humans. Proc Natl Acad Sci USA. 2001, 98: 658-663.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3871_CR7","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1128\/JVI.73.5.4009-4018.1999","volume":"73","author":"JR Mascola","year":"1999","unstructured":"Mascola JR, Lewis MG, Stiegler G, Harris D, VanCott TC, Hayes D, Louder MK, Brown CR, Sapan CV, Frankel SS, et al: Protection of macaques against pathogenic simian\/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies. J Virol. 1999, 73: 4009-4018.","journal-title":"J Virol"},{"key":"3871_CR8","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/72318","volume":"6","author":"JR Mascola","year":"2000","unstructured":"Mascola JR, Stiegler G, VanCott TC, Katinger H, Carpenter CB, Hanson CE, Beary H, Hayes D, Frankel SS, Birx DL, Lewis MG: Protection of macaques against vaginal transmission of a pathogenic HIV-1\/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat Med. 2000, 6: 207-210.","journal-title":"Nat Med"},{"key":"3871_CR9","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/5568","volume":"5","author":"R Shibata","year":"1999","unstructured":"Shibata R, Igarashi T, Haigwood N, Buckler-White A, Ogert R, Ross W, Willey R, Cho MW, MartinMalcolm A: Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1\/SIV chimeric virus infections of macaque monkeys. Nat Med. 1999, 5: 204-210.","journal-title":"Nat Med"},{"key":"3871_CR10","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/nm.2233","volume":"16","author":"CT Ng","year":"2010","unstructured":"Ng CT, Jaworski JP, Jayaraman P, Sutton WF, Delio P, Kuller L, Anderson D, Landucci G, Richardson BA, Burton DR, et al: Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques. Nat Med. 2010, 16: 1117-1119.","journal-title":"Nat Med"},{"key":"3871_CR11","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1128\/JVI.02066-08","volume":"83","author":"NB Siddappa","year":"2009","unstructured":"Siddappa NB, Song R, Kramer VG, Chenine AL, Velu V, Ong H, Rasmussen RA, Grisson RD, Wood C, Zhang H, et al: Neutralization-sensitive R5-tropic simian-human immunodeficiency virus SHIV-2873Nip, which carries env isolated from an infant with a recent HIV clade C infection. J Virol. 2009, 83: 1422-1432.","journal-title":"J Virol"},{"key":"3871_CR12","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/1742-4690-5-94","volume":"5","author":"M Humbert","year":"2008","unstructured":"Humbert M, Rasmussen RA, Song R, Ong H, Sharma P, Chenine AL, Kramer VG, Siddappa NB, Xu W, Else JG, et al: SHIV-1157i and passaged progeny viruses encoding R5 HIV-1 clade C env cause AIDS in rhesus monkeys. Retrovirology. 2008, 5: 94-","journal-title":"Retrovirology"},{"key":"3871_CR13","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1128\/IAI.01703-06","volume":"75","author":"M Ayash-Rashkovsky","year":"2007","unstructured":"Ayash-Rashkovsky M, Chenine AL, Steele LN, Lee SJ, Song R, Ong H, Rasmussen RA, Hofmann-Lehmann R, Else JG, Augostini P, et al: Coinfection with Schistosoma mansoni reactivates viremia in rhesus macaques with chronic simian-human immunodeficiency virus clade C infection. Infect Immun. 2007, 75: 1751-1756.","journal-title":"Infect Immun"},{"key":"3871_CR14","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1097\/QAD.0b013e32828684ea","volume":"21","author":"RA Rasmussen","year":"2007","unstructured":"Rasmussen RA, Ong H, Song R, Chenine AL, Ayash-Rashkovsky M, Hu SL, Polacino P, Else JG, Novembre FJ, Ruprecht RM: Efficacy of a multigenic protein vaccine containing multimeric HIV gp160 against heterologous SHIV clade C challenges. AIDS. 2007, 21: 1841-1848.","journal-title":"AIDS"},{"key":"3871_CR15","doi-asserted-by":"publisher","first-page":"8729","DOI":"10.1128\/JVI.00558-06","volume":"80","author":"RJ Song","year":"2006","unstructured":"Song RJ, Chenine AL, Rasmussen RA, Ruprecht CR, Mirshahidi S, Grisson RD, Xu W, Whitney JB, Goins LM, Ong H, et al: Molecularly cloned SHIV-1157ipd3N4: a highly replication- competent, mucosally transmissible R5 simian-human immunodeficiency virus encoding HIV clade C Env. J Virol. 2006, 80: 8729-8738.","journal-title":"J Virol"},{"key":"3871_CR16","doi-asserted-by":"publisher","first-page":"11651","DOI":"10.1128\/JVI.01762-08","volume":"82","author":"JM Binley","year":"2008","unstructured":"Binley JM, Lybarger EA, Crooks ET, Seaman MS, Gray E, Davis KL, Decker JM, Wycuff D, Harris L, Hawkins N, et al: Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C. J Virol. 2008, 82: 11651-11668.","journal-title":"J Virol"},{"key":"3871_CR17","doi-asserted-by":"publisher","first-page":"e29454","DOI":"10.1371\/journal.pone.0029454","volume":"7","author":"BK Brown","year":"2012","unstructured":"Brown BK, Wieczorek L, Kijak G, Lombardi K, Currier J, Wesberry M, Kappes JC, Ngauy V, Marovich M, Michael N, et al: The role of natural killer (NK) cells and NK cell receptor polymorphisms in the assessment of HIV-1 neutralization. PLoS ONE. 2012, 7: e29454-","journal-title":"PLoS ONE"},{"key":"3871_CR18","doi-asserted-by":"publisher","first-page":"a007070","DOI":"10.1101\/cshperspect.a007070","volume":"2","author":"M Carrington","year":"2012","unstructured":"Carrington M, Alter G: Innate Immune Control of HIV. Cold Spring Harb Perspect Med. 2012, 2: a007070-","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3871_CR19","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1128\/jvi.76.5.2123-2130.2002","volume":"76","author":"Y Nishimura","year":"2002","unstructured":"Nishimura Y, Igarashi T, Haigwood N, Sadjadpour R, Plishka RJ, Buckler-White A, Shibata R, Martin MA: Determination of a statistically valid neutralization titer in plasma that confers protection against simian-human immunodeficiency virus challenge following passive transfer of high-titered neutralizing antibodies. J Virol. 2002, 76: 2123-2130.","journal-title":"J Virol"},{"key":"3871_CR20","doi-asserted-by":"publisher","first-page":"15131","DOI":"10.1073\/pnas.2436476100","volume":"100","author":"Y Nishimura","year":"2003","unstructured":"Nishimura Y, Igarashi T, Haigwood NL, Sadjadpour R, Donau OK, Buckler C, Plishka RJ, Buckler-White A, Martin MA: Transfer of neutralizing IgG to macaques 6\u00a0h but not 24\u00a0h after SHIV infection confers sterilizing protection: implications for HIV-1 vaccine development. Proc Natl Acad Sci USA. 2003, 100: 15131-15136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3871_CR21","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1182\/blood-2012-05-431361","volume":"120","author":"DN Forthal","year":"2012","unstructured":"Forthal DN, Gabriel EE, Wang A, Landucci G, Phan TB: Association of Fcgamma receptor IIIa genotype with the rate of HIV infection after gp120 vaccination. Blood. 2012, 120: 2836-2842.","journal-title":"Blood"},{"key":"3871_CR22","doi-asserted-by":"publisher","first-page":"13026","DOI":"10.1073\/pnas.0404739101","volume":"101","author":"SI Staprans","year":"2004","unstructured":"Staprans SI, Barry AP, Silvestri G, Safrit JT, Kozyr N, Sumpter B, Nguyen H, McClure H, Montefiori D, Cohen JI, Feinberg MB: Enhanced SIV replication and accelerated progression to AIDS in macaques primed to mount a CD4 T cell response to the SIV envelope protein. Proc Natl Acad Sci USA. 2004, 101: 13026-13031.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3871_CR23","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0165-2427(92)90131-9","volume":"35","author":"MJ Hosie","year":"1992","unstructured":"Hosie MJ, Osborne R, Reid G, Neil JC, Jarrett O: Enhancement after feline immunodeficiency virus vaccination. Vet Immunol Immunopathol. 1992, 35: 191-197.","journal-title":"Vet Immunol Immunopathol"},{"key":"3871_CR24","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1128\/jvi.69.6.3704-3711.1995","volume":"69","author":"KH Siebelink","year":"1995","unstructured":"Siebelink KH, Tijhaar E, Huisman RC, Huisman W, de Ronde A, Darby IH, Francis MJ, Rimmelzwaan GF, Osterhaus AD: Enhancement of feline immunodeficiency virus infection after immunization with envelope glycoprotein subunit vaccines. J Virol. 1995, 69: 3704-3711.","journal-title":"J Virol"},{"key":"3871_CR25","doi-asserted-by":"crossref","first-page":"9640","DOI":"10.1128\/jvi.71.12.9640-9649.1997","volume":"71","author":"J Richardson","year":"1997","unstructured":"Richardson J, Moraillon A, Baud S, Cuisinier AM, Sonigo P, Pancino G: Enhancement of feline immunodeficiency virus (FIV) infection after DNA vaccination with the FIV envelope. J Virol. 1997, 71: 9640-9649.","journal-title":"J Virol"},{"key":"3871_CR26","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1006\/viro.1999.9939","volume":"262","author":"SA Hammond","year":"1999","unstructured":"Hammond SA, Raabe ML, Issel CJ, Montelaro RC: Evaluation of antibody parameters as potential correlates of protection or enhancement by experimental vaccines to equine infectious anemia virus. Virology. 1999, 262: 416-430.","journal-title":"Virology"},{"key":"3871_CR27","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1126\/science.3277268","volume":"239","author":"SB Halstead","year":"1988","unstructured":"Halstead SB: Pathogenesis of dengue: challenges to molecular biology. Science. 1988, 239: 476-481.","journal-title":"Science"},{"key":"3871_CR28","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1126\/science.1185181","volume":"328","author":"W Dejnirattisai","year":"2010","unstructured":"Dejnirattisai W, Jumnainsong A, Onsirisakul N, Fitton P, Vasanawathana S, Limpitikul W, Puttikhunt C, Edwards C, Duangchinda T, Supasa S, et al: Cross-reacting antibodies enhance dengue virus infection in humans. Science. 2010, 328: 745-748.","journal-title":"Science"},{"key":"3871_CR29","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1099\/vir.0.18980-0","volume":"84","author":"MJ Wallace","year":"2003","unstructured":"Wallace MJ, Smith DW, Broom AK, Mackenzie JS, Hall RA, Shellam GR, McMinn PC: Antibody-dependent enhancement of Murray Valley encephalitis virus virulence in mice. J Gen Virol. 2003, 84: 1723-1728.","journal-title":"J Gen Virol"},{"key":"3871_CR30","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1086\/374604","volume":"187","author":"EM Ponnuraj","year":"2003","unstructured":"Ponnuraj EM, Springer J, Hayward AR, Wilson H, Simoes EA: Antibody-dependent enhancement, a possible mechanism in augmented pulmonary disease of respiratory syncytial virus in the Bonnet monkey model. J Infect Dis. 2003, 187: 1257-1263.","journal-title":"J Infect Dis"},{"key":"3871_CR31","doi-asserted-by":"publisher","first-page":"7539","DOI":"10.1128\/JVI.77.13.7539-7544.2003","volume":"77","author":"A Takada","year":"2003","unstructured":"Takada A, Feldmann H, Ksiazek TG, Kawaoka Y: Antibody-dependent enhancement of Ebola virus infection. J Virol. 2003, 77: 7539-7544.","journal-title":"J Virol"},{"key":"3871_CR32","doi-asserted-by":"publisher","first-page":"8530","DOI":"10.1128\/JVI.00593-06","volume":"80","author":"ID Iankov","year":"2006","unstructured":"Iankov ID, Pandey M, Harvey M, Griesmann GE, Federspiel MJ, Russell SJ: Immunoglobulin G antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response. J Virol. 2006, 80: 8530-8540.","journal-title":"J Virol"},{"key":"3871_CR33","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/QAI.0b013e31822f8914","volume":"58","author":"C Onyango-Makumbi","year":"2011","unstructured":"Onyango-Makumbi C, Omer SB, Mubiru M, Moulton LH, Nakabiito C, Musoke P, Mmiro F, Zwerski S, Wigzell H, Falksveden L, et al: Safety and efficacy of HIV hyper immune globulin for prevention of mother-to-child HIV transmission in HIV-1-infected pregnant women and their infants in Kampala, Uganda (HIVIGLOB\/NVP STUDY). J Acquir Immune Defic Syndr. 2011, 58: 399-407.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"3871_CR34","doi-asserted-by":"publisher","first-page":"11181","DOI":"10.1073\/pnas.1103012108","volume":"108","author":"DR Burton","year":"2011","unstructured":"Burton DR, Hessell AJ, Keele BF, Klasse PJ, Ketas TA, Moldt B, Dunlop DC, Poignard P, Doyle LA, Cavacini L, et al: Limited or no protection by weakly or non-neutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody. Proc Natl Acad Sci USA. 2011, 108: 11181-11186.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3871_CR35","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1089\/aid.1990.6.999","volume":"6","author":"A Takeda","year":"1990","unstructured":"Takeda A, Ennis FA: FcR-mediated enhancement of HIV-1 infection by antibody. AIDS Res Hum Retroviruses. 1990, 6: 999-1004.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"3871_CR36","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/S0140-6736(88)91657-1","volume":"1","author":"WE Robinson Jr","year":"1988","unstructured":"Robinson WE, Montefiori DC, Mitchell WM: Antibody-dependent enhancement of human immunodeficiency virus type 1 infection. Lancet. 1988, 1: 790-794.","journal-title":"Lancet"},{"key":"3871_CR37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1742-4690-8-16","volume":"8","author":"S Willey","year":"2011","unstructured":"Willey S, Aasa-Chapman MM, O\u2019Farrell S, Pellegrino P, Williams I, Weiss RA, Neil SJ: Extensive complement-dependent enhancement of HIV-1 by autologous non-neutralising antibodies at early stages of infection. Retrovirology. 2011, 8: 16-","journal-title":"Retrovirology"},{"issue":"Suppl 8","key":"3871_CR38","doi-asserted-by":"publisher","first-page":"I79","DOI":"10.1016\/j.vaccine.2008.11.050","volume":"26","author":"H Stoiber","year":"2008","unstructured":"Stoiber H, Soederholm A, Wilflingseder D, Gusenbauer S, Hildgartner A, Dierich MP: Complement and antibodies: a dangerous liaison in HIV infection?. Vaccine. 2008, 26 (Suppl 8): I79-I85.","journal-title":"Vaccine"},{"key":"3871_CR39","unstructured":"NIH discontinues immunizations in HIV vaccine study. http:\/\/www.niaid.nih.gov\/news\/newsreleases\/2013\/Pages\/HVTN505April2013.aspx,"},{"key":"3871_CR40","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1128\/jvi.67.7.3978-3988.1993","volume":"67","author":"M Thali","year":"1993","unstructured":"Thali M, Moore JP, Furman C, Charles M, Ho DD, Robinson J, Sodroski J: Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. J Virol. 1993, 67: 3978-3988.","journal-title":"J Virol"},{"issue":"12","key":"3871_CR41","first-page":"11","volume":"12","author":"DC Montefiori","year":"2005","unstructured":"Montefiori DC: Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays. Curr Protoc Immunol. 2005, 12 (12): 11-","journal-title":"Curr Protoc Immunol"},{"key":"3871_CR42","doi-asserted-by":"publisher","first-page":"e18207","DOI":"10.1371\/journal.pone.0018207","volume":"6","author":"JD Watkins","year":"2011","unstructured":"Watkins JD, Siddappa NB, Lakhashe SK, Humbert M, Sholukh A, Hemashettar G, Wong YL, Yoon JK, Wang W, Novembre FJ, et al: An anti-HIV-1\u00a0V3 loop antibody fully protects cross-clade and elicits T-cell immunity in macaques mucosally challenged with an R5 clade C SHIV. PLoS ONE. 2011, 6: e18207-","journal-title":"PLoS ONE"},{"key":"3871_CR43","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature06106","volume":"449","author":"AJ Hessell","year":"2007","unstructured":"Hessell AJ, Hangartner L, Hunter M, Havenith CE, Beurskens FJ, Bakker JM, Lanigan CM, Landucci G, Forthal DN, Parren PW, et al: Fc receptor but not complement binding is important in antibody protection against HIV. Nature. 2007, 449: 101-104.","journal-title":"Nature"},{"key":"3871_CR44","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jim.2005.09.018","volume":"308","author":"VR Gomez-Roman","year":"2006","unstructured":"Gomez-Roman VR, Florese RH, Patterson LJ, Peng B, Venzon D, Aldrich K, Robert-Guroff M: A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity. J Immunol Methods. 2006, 308: 53-67.","journal-title":"J Immunol Methods"},{"key":"3871_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virol.2010.08.028","volume":"408","author":"TG Edmonds","year":"2010","unstructured":"Edmonds TG, Ding H, Yuan X, Wei Q, Smith KS, Conway JA, Wieczorek L, Brown B, Polonis V, West JT, et al: Replication competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the analysis of antibody inhibition in PBMC. Virology. 2010, 408: 1-13.","journal-title":"Virology"},{"key":"3871_CR46","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1084\/jem.20082831","volume":"206","author":"BF Keele","year":"2009","unstructured":"Keele BF, Li H, Learn GH, Hraber P, Giorgi EE, Grayson T, Sun C, Chen Y, Yeh WW, Letvin NL, et al: Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1. J Exp Med. 2009, 206: 1117-1134.","journal-title":"J Exp Med"},{"key":"3871_CR47","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1084\/jem.20090378","volume":"206","author":"JF Salazar-Gonzalez","year":"2009","unstructured":"Salazar-Gonzalez JF, Salazar MG, Keele BF, Learn GH, Giorgi EE, Li H, Decker JM, Wang S, Baalwa J, Kraus MH, et al: Genetic identity, biological phenotype, and evolutionary pathways of transmitted\/founder viruses in acute and early HIV-1 infection. J Exp Med. 2009, 206: 1273-1289.","journal-title":"J Exp Med"}],"container-title":["Retrovirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-4690-11-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T02:49:27Z","timestamp":1630550967000},"score":1,"resource":{"primary":{"URL":"https:\/\/retrovirology.biomedcentral.com\/articles\/10.1186\/1742-4690-11-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,20]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["3871"],"URL":"https:\/\/doi.org\/10.1186\/1742-4690-11-8","relation":{},"ISSN":["1742-4690"],"issn-type":[{"value":"1742-4690","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,20]]},"assertion":[{"value":"24 September 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"8"}}